Skip to main content
Erschienen in: BMC Public Health 1/2019

Open Access 01.12.2019 | Research article

Arab world’s growing contribution to global leishmaniasis research (1998–2017): a bibliometric study

verfasst von: Samah W. Al-Jabi

Erschienen in: BMC Public Health | Ausgabe 1/2019

Abstract

Background

Leishmaniasis is a parasitic disease caused by a protozoan of the Leishmania genus, and is considered a neglected tropical disease. It still remains a main public health concern at global level and in Arab world mainly in low-income countries. Therefore, this study was designed to evaluate the Arab world’s growing contribution to global leishmaniasis research.

Methods

This study describes a bibliometric review of all leishmaniasis research publications published between January 1998 and December 2017 indexed on the Scopus database.

Results

The total number of publications published at global level was 17,570 papers, which achieves an average annual productivity of 878.50 papers publications. Brazil was responsible for the greatest output with the total number of publications of 3865 followed by the Unites States (n = 2729), India (n = 2119), the United Kingdom (n = 1363), and Spain (n = 1274). By limiting the analysis to the publications that have been published by Arab world, the research productivity was 993 papers, which represents 5.65% of total research output at global level in research regarding leishmaniasis. Tunisia was responsible for the greatest output from Arab world with the total number of publications of 297 followed by Sudan (n = 192), Saudi Arabia (n = 131), Morocco (n = 119) and Egypt (n = 67). Since 1998, the growth of publications on leishmaniasis fluctuates, overall showing a rising trend in both global and Arab world. There is a highly significant correlation between publication productivity related to leishmaniasis at global level and the Arab world (r = 0.936; p-value< 0.001). Leishmaniasis treatment, intracellular mechanism of infection, and lifecycle of leishmania are the major current hot topics for the research in this subject at global level and the Arab world.

Conclusions

The current study presents a novel review of the current Arab leishmaniasis-related research, and how these results are related to worldwide output. In comparison to the global research output, the Arab world produced less leishmaniasis research. The data presented in the current study by this innovative approach may serve relevant researchers to direct the global leishmaniasis research to Arab counties in which leishmaniasis is endemic.
Abkürzungen
GDP
Gross domestic product
IFs
Impact factors
IQR
Interquartile range
JCR
Journal Citation Report
SPSS
Statistical Package for Social Sciences
WHO
World Health Organization

Background

Leishmaniasis is a parasitic disease caused by a protozoan of the Leishmania genus, and is considered a neglected tropical disease [1]. It is transmitted by the bite of infected female phlebotomine sand flies to mammals, including human beings [2, 3]. The most common types of leishmaniasis are visceral leishmaniasis, cutaneous leishmaniasis, and mucocutaneous leishmaniasis [4]. According to World Health Organization (WHO) update (2017), leishmaniasis is the main parasitic killer responsible for an estimated one million new cases of leishmaniasis and 20,000 to 30,000 deaths annually [5].
The clinical manifestations of leishmaniasis can range from subclinical (inapparent), or a self-resolving cutaneous ulcer to a disseminated infection (cutaneous, mucosal, or visceral) and even to a lethal systemic illness [610]. Leishmania infects some of the poorest people in the world, and is linked to population displacement, malnutrition lack of financial resources, and poor housing [5]. Leishmaniasis is a public health problem and it is endemic in many parts of the tropics, subtropics and the Mediterranean [11, 12]. Middle Eastern countries including Arab world’s countries are currently considered to be at risk from leishmaniasis because these countries are endemic for visceral and cutaneous leishmaniasis, and a huge deal of human migration from neighbouring countries is observed [1317].
To encourage and strengthen research capacity in the field of neglected tropical diseases, including leishmaniasis, the WHO highlights the periodic review and development of present and national research agendas [18]. A number of global bibliometric studies exist in various infectious diseases [1922], including tropical medicine [2326]. In addition, several studies have evaluated the research output for leishmaniasis [25, 2730]. Previous reports about leishmaniasis have mainly assessed the research output of international studies, and paid less interest on leishmaniasis research structure in Arab world. In other words, there is a lack of bibliometric studies regarding leishmaniasis in Arab world that evaluates the research output in a qualitative and a quantitative way, and the relationship among research hot topics was not revealed obviously. Therefore, it is essential to evaluate the scientific research output of the Arab world relative to that worldwide. In particular, the current study aimed to analyze the contribution of the Arab scientific community with regard to global contribution in (i) leishmaniasis literature during the last two decades; (ii) international collaborative patterns; (iii) productivity of the most active institutions; (iv) productivity of the most relevant journals; (v) characteristics of highly cited papers; and (vi) hot research topics. The data in this study can present a clear picture on the research growth accomplished in the field of leishmaniasis research, and it can aid researchers and practitioners in recognizing fundamental influences of this field.

Methods

All leishmaniasis research publications published between January 1998 and December 2017 indexed on the Scopus database were analysed while the ones published in 2018 were excluded because Scopus as a secondary source has not yet archived all the publications from the primary sources for this year. The Scopus was used because it is the most widely accepted and frequently used database for analysis of scientific publications in different fields [22, 3134]. The search was completed in November 2018. A bibliometric filter to capture leishmaniasis related publications from the Scopus database was created by using the key words ‘leishmaniosis, or ‘Leishmaniasis’ or ‘leishmania’ or ‘kala-azar’ in the ‘title’ selection mode.
All documents referring to leishmaniasis research during the last two decades were assessed with the following aspects: document types, languages, yearly publications, countries and collaboration patterns, institutions, journals, h-index, citations, and research hotspots. The analysis focused on providing outputs for the top ten prolific of the following: countries, journals with their impact factors (IF), cited articles, and institutions as in the most previous bibliometric studies [19, 33, 3537]. In the current study, IF for the most prolific journals were extracted according to the 2017 journal citation report (JCR) at the time of study. Based on downloaded publications from Scopus database, bibliometric maps were created to determine the hot topics using the VOSviewer software version 1.6.9 (freely available at www.​vosviewer.​com). The collected data from the Scopus were limited to all 22 Arab countries, including “Algeria, Bahrain, Comoros, Djibouti, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Mauritania, Oman, Palestine, Qatar, Syrian Arab Republic, Saudi Arabia, Sudan, Somalia, Tunisia, United Arab Emirates, and Yemen” [38].

Statistical analysis

The Statistical Package for Social Sciences (SPSS) software version 16 was applied for analysis, while graphical research output was also conducted in Microsoft Excel. Pearson correlation coefficient was used to analyze trends in publication between publication productivity related to leishmaniasis at global level and productivity related to leishmaniasis from Arab world.

Results

The total number of publications published between 1998 and 2017 at global level was 17,570 papers, which achieves an average annual productivity of 878.50 papers. The global research output consists of 15,021 articles (85.49%), followed by reviews (1175 papers, 6.69%), letters to the editor (615 papers, 3.50%). The remainders were other types (759 papers, 4.32%). Retrieved publications were written in 30 different languages, mainly English (n = 16,002; 91.08%) followed by Portuguese (n = 545; 3.10%), Spanish (n = 443; 2.52%), and French (n = 362; 2.06%). By limiting the analysis to the publications that have been published by Arab world, the research productivity was 993 papers during 1998–2017, which represents 5.65% of total scientific research output at global level in research related to leishmaniasis. The Arab world research output consists of 881 articles (88.72%), followed by reviews (51 papers, 5.14%), and letters to the editor (37 papers, 3.73%). The remainders were other types (24 papers, 2.42%). Retrieved publications from Arab world were written in 6 different languages, mainly English (n = 882; 88.82%). Since 1998, the growth of publications on leishmaniasis fluctuates, overall showing a rising trend in both global and Arab world (Fig. 1). There is a highly significant correlation between publication productivity related to leishmaniasis at global level and the Arab world (r = 0.936; p-value < 0.001).
A total of 135 countries worldwide contributed to the literature on leishmaniasis over the study period. The publications share of the top 10 most productive countries in leishmaniasis research ranges from 22.00% for Brazil to 3.35% for Canada during 1998–2017. Table 1 shows the top 10 top-ranking countries at global level in terms of relative contribution of each country to the total number of publications. Brazil was responsible for the greatest output with the total number of publications of 3865 followed by the Unites States (n = 2729), India (n = 2119), the United Kingdom (n = 1363) and Spain (n = 1274); (Table 1). The highest h-index value was 119 for the USA, followed by 102 for the UK, 83 for Brazil, 83 for India, and 82 for Germany. The USA, with the largest number of international collaboration publications (n = 1633), led this productivity rank followed by the UK (n = 937).
Table 1
Contribution and impact of the top 10 countries at global level in leishmaniasis research during 1998–2017
SCR
Country
Number of documents (%)
h-index
Number of collaborating countries
International collaborative publications
1st
Brazil
3865 (22.00)
83
64
910
2nd
USA
2729 (15.53)
119
100
1633
3rd
India
2119 (12.06)
83
68
558
4th
UK
1363 (7.76)
102
81
937
5th
Spain
1274 (7.25)
70
68
546
6th
Iran
1272 (7.24)
52
42
180
7th
France
1055 (6.00)
80
77
582
8th
Germany
839 (4.78)
82
68
522
9th
Italy
714 (4.06)
57
57
253
10th
Canada
588 (3.35)
75
55
341
SCR Standard competition ranking
Table 2 shows the ranking of Arab countries with relative contribution of each country to the total number of publications from Arab world. Tunisia was responsible for the greatest output with the total number of publications of 297 followed by Sudan (n = 192), Saudi Arabia (n = 131), Morocco (n = 119) and Egypt (n = 67); (Table 2). The highest h-index value for Arab countries was achieved by Sudan (43) followed by Tunisia (31), Morocco (21), Saudi Arabia (20), and Palestine (18). The Arab countries have collaborated with 52 countries/ territories in leishmaniasis research (Table 3).
Table 2
Ranking and contribution the Arab countries in leishmaniasis research during 1998–2017
SCRa
Country
Number of documents (%)
h-index
Number of collaborating countries
International collaborative publications
1st
Tunisia
297 (29.91)
31
38
125
2nd
Sudan
192 (19.34)
43
42
163
3rd
Saudi Arabia
131 (13.19)
20
36
92
4th
Morocco
119 (11.98)
21
24
45
5th
Egypt
67 (6.75)
15
29
55
6th
Algeria
61 (6.14)
14
24
45
7th
Iraq
44 (4.43)
9
6
10
8th
Palestine
40 (4.03)
18
23
40
9th
Syrian Arab Republic
37 (3.73)
11
23
15
10th
Lebanon
33 (3.32)
12
11
17
11th
Yemen
25 (2.52)
9
10
15
12th
Jordan
15 (1.51)
7
11
11
13th
Libyan Arab Jamahiriya
12 (12.1)
7
9
10
13th
Oman
12 (1.21)
6
3
6
15th
Bahrain
9 (0.91)
5
5
5
16th
Kuwait
6 (0.60)
5
4
3
17th
Qatar
5 (0.50)
3
5
5
18th
United Arab Emirates
4 (0.40)
2
2
2
19th
Somalia
1 (0.10)
1
2
1
SCR Standard competition ranking
a Equal countries have the same ranking number, and then a gap is left in the ranking numbers
Table 3
Collaboration between Arab countries and non-Arab countries in leishmaniasis research during 1998–2017
Country
Number of documents
%
Country
Number of documents
%
France
132
13.29
Greece
6
0.60
United States
99
9.97
Nepal
6
0.60
United Kingdom
88
8.86
Colombia
5
0.50
Germany
51
5.14
Czech Republic
5
0.50
Belgium
47
4.73
Japan
5
0.50
Netherlands
43
4.33
Nigeria
4
0.40
Switzerland
39
3.93
Turkey
4
0.40
India
37
3.73
Cuba
3
0.30
Israel
29
2.92
Russian Federation
3
0.30
Spain
24
2.42
South Africa
3
0.30
Kenya
23
2.32
Austria
2
0.20
Brazil
20
2.01
Ghana
2
0.20
Ethiopia
17
1.71
Luxembourg
2
0.20
Pakistan
17
1.71
Malaysia
2
0.20
Italy
15
1.51
Uzbekistan
2
0.20
Canada
14
1.41
Venezuela
2
0.20
Sweden
14
1.41
Albania
1
0.10
Denmark
13
1.31
Burkina Faso
1
0.10
Uganda
12
1.21
Congo
1
0.10
Iran
10
1.01
Croatia
1
0.10
Australia
9
0.91
Ecuador
1
0.10
Malawi
9
0.91
Guatemala
1
0.10
Portugal
9
0.91
Hong Kong
1
0.10
Bangladesh
7
0.70
Mexico
1
0.10
Peru
7
0.70
Singapore
1
0.10
China
6
0.60
Thailand
1
0.10
Top 10 journals with the most publications at global level are presented in Table 4, representing 3505 publications accounting for 19.95% of the total publications. The most prolific journals in the field of leishmaniasis were Plos Neglected Tropical Diseases (n = 523, I.F. = 4.367), American Journal of Tropical Medicine and Hygiene (n = 492, I.F = 2.564), and Experimental Parasitology (n = 364, I.F. = 1.821). While Table 5 shows the top 10 journals with most of the publications from Arab world, representing 302 publications accounting for 30.41% of the total publications. The Acta Tropica published most of the publications (n = 46, I.F = 2.509), followed by Transactions of the Royal Society of Tropical Medicine and Hygiene (n = 44, I.F. = 2.820), and Plos Neglected Tropical Diseases (n = 42, I.F. = 4.367).
Table 4
Top 10 journals related to leishmaniasis research at global level during 1998–2017
SCRa
Journal
Number of documents (%)
IFb
1st
Plos Neglected Tropical Diseases
523 (2.98)
4.367
2nd
American Journal of Tropical Medicine and Hygiene
492 (2.80)
2.564
3rd
Experimental Parasitology
364 (2.07)
1.821
4th
Acta Tropica
354 (2.01)
2.509
5th
Plos One
321 (1.83)
2.766
6th
Transactions of the Royal Society of Tropical Medicine and Hygiene
307 (1.75)
2.820
7th
Veterinary Parasitology
291 (1.66)
2.422
8th
Memorias do Instituto Oswaldo Cruz
286 (1.63)
2.833
8th
Revista da Sociedade Brasileira de Medicina Tropical
286 (1.63)
1.358
10th
Molecular and Biochemical Parasitology
281 (1.60)
1.744
SCR Standard competition ranking; IF, Impact factor
a Equal journals have the same ranking number, and then a gap is left in the ranking numbers
b Impact factors (IF) based on Journal Citation Reports (JCR) 2017 from Clarivate Analytics
Table 5
Top 10 journals related to leishmaniasis research from Arab world during 1998–2017
SCR
Journal
Number of documents (%)
IFa
1st
Acta Tropica
46 (4.63)
2.509
2nd
Transactions of the Royal Society of Tropical Medicine and Hygiene
44 (4.43)
2.820
3rd
Plos Neglected Tropical Diseases
42 (4.23)
4.367
4th
Parasites and Vectors
33 (3.32)
3.163
5th
American Journal of Tropical Medicine and Hygiene
32 (3.22)
2.564
6th
Plos One
25 (2.52)
2.766
7th
Bulletin de La Societe de Pathologie Exotique
24 (2.42)
NA
8th
Annals of Tropical Medicine and Parasitology b
20 (2.01)
1.703
9th
Tropical Medicine and International Health
19 (1.91)
2.541
10th
Saudi Medical Journal
17 (1.71)
1.055
SCR Standard competition ranking; IF, Impact factor; NA, not available
a Impact factors (IF) based on Journal Citation Reports (JCR) 2017 from Clarivate Analytics
b Currently known as: Pathogens and Global Health (2012 - current)
Figure 2 illustrates the term map of the global hot topics of leishmaniasis research over the period of 1998–2017 as extracted from titles and abstracts of publications. The term map was set up based on 952 terms encompass 4 main clusters in four colors: red, green, yellow, and blue. The red cluster included terms that were mainly related to the leishmaniasis causes and epidemiology research topics. The yellow cluster included terms closely related to treatment research topics. The green cluster included terms mainly related to the intracellular mechanism of infection. Blue cluster included terms roughly related to the lifecycle of leishmania. Whereas Fig. 3 illustrates the term map of the Arab world hot topics of leishmaniasis research over the period of 1998–2017 as extracted from titles and abstracts of publications. The term map was set up based on 319 terms encompass 4 main clusters in four colors: red, green, yellow, and blue. The red cluster included terms that were mainly related to the lifecycle of leishmania. Green cluster included terms roughly related to the intracellular mechanism of infection. Blue cluster included terms that were mainly related to the prevention, and treatment. The yellow cluster included terms closely related to the immunology of leishmaniasis.
The top 10 most cited publications [6, 3947] at global level on leishmaniasis are presented in Table 6. From 1998 to 2017, the most frequently cited publication “Leishmaniasis: Current situation and new perspectives” published by Comparative Immunology, Microbiology and Infectious Diseases was from Switzerland by Desjeux [43] in 2004. The top 10 most cited publications [10, 4856] from Arab world on leishmaniasis are presented in Table 7. From 1998 to 2017, the most frequently cited publication “Cutaneous leishmaniasis” published by Lancet Infectious Diseases was from Tunisia with international collaboration by Reithinger et al. [10] in 2007.
Table 6
Most 10 frequently cited publications on leishmaniasis research at global level during 1998–2017
SCR
Authors
Title
year of publication
Source title
Cited by
1st
Desjeux [43]
Leishmaniasis: Current situation and new perspectives
2004
Comparative Immunology, Microbiology and Infectious Diseases
1971
2nd
Alvar et al. [39]
Leishmaniasis worldwide and global estimates of its incidence
2012
PLoS ONE
1400
3rd
Belkaid et al. [40]
CD4 + CD25+ regulatory T cells control Leishmania major persistence and immunity
2002
Nature
1277
4th
Herwaldt [44]
Leishmaniasis
1999
Lancet
1204
5th
Murray et al. [6]
Advances in leishmaniasis
2005
Lancet
1079
6th
Croft et al. [41]
Drug resistance in leishmaniasis
2006
Clinical Microbiology Reviews
977
7th
Ivens et al. [45]
The genome of the kinetoplastid parasite, Leishmania major
2005
Science
912
8th
Darrah et al. [42]
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
2007
Nature Medicine
880
9th
Sacks et al. [46]
The immunology of susceptibility and resistance to Leishmania major in mice
2002
Nature Reviews Immunology
764
10th
Chappuis et al. [47]
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
2007
Nature Reviews Microbiology
704
SCR Standard competition ranking
Table 7
Most 10 frequently cited publications on leishmaniasis research from Arab world during 1998–2017
SCR
Authors
Title
year of publication
Source title
Cited by
1st
Reithinger et al. [10]
Cutaneous leishmaniasis
2007
Lancet Infectious Diseases
685
2nd
Zijlstra et al. [55]
Post-kala-azar dermal leishmaniasis
2003
Lancet Infectious Diseases
282
3rd
Alrajhi et al. [48]
Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major
2002
New England Journal of Medicine
234
4th
El Tai et al. [51]
Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing
2000
Transactions of the Royal Society of Tropical Medicine and Hygiene
199
5th
Bacaër and Guernaoui [50]
The epidemic threshold of vector-borne diseases with seasonality: The case of cutaneous leishmaniasis in Chichaoua, Morocco
2006
Journal of Mathematical Biology
181
6th
Khalil et al. [52]
Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: A randomised, double-blind, BCG-controlled trial in Sudan
2000
Lancet
173
7th
Arnoult et al. [49]
On the evolution of programmed cell death: Apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization
2002
Cell Death and Differentiation
165
8th
Postigo [54]
Leishmaniasis in the World Health Organization Eastern Mediterranean Region
2010
International Journal of Antimicrobial Agents
148
9th
Pitta et al. [53]
IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani
2009
Journal of Clinical Investigation
146
10th
Zijlstra et al. [56]
Diagnosing visceral leishmaniasis with the recombinant K39 strip test: Experience from the Sudan
2001
Tropical Medicine and International Health
140
SCR Standard competition ranking
Table 8 presents the performances of the top 10 most prolific institutes in the field of leishmaniasis between 1998 and 2017 at global level, representing 5498 publications accounting for 31.29% of the total publications. Five of these ten institutes were located in Brazil. The Fundacao Oswaldo Cruz is the largest contributor publishing 1427 publications on leishmaniasis. The Universidade de Sao Paulo in Brazil, the Universidade Federal de Minas Gerais in Brazil, the Tehran University of Medical Sciences in Iran, and Universidade Federal do Rio de Janeiro in Brazil, ranked second to fifth, contributing 769, 562, 503, and 485 publications, respectively. Table 9 presents the performances of the top 10 most productive institutes in the field of leishmaniasis between 1998 and 2017 from Arab world or from international collaboration, representing 640 publications accounting for 64.45% of the total publications. The Institut Pasteur de Tunis is the largest contributor publishing 178 publications on leishmaniasis. The Khartoum University in Sudan, and the Institute of Endemic Diseases Sudan in Sudan, ranked second and third, contributing 147, and 82 publications, respectively.
Table 8
Top 10 institutions most productive of research publications on leishmaniasis at global level during 1998–2017
SCR
Institute
Country
Number of documents (%)
1st
Fundacao Oswaldo Cruz
Brazil
1427 (8.12)
2nd
Universidade de Sao Paulo
Brazil
769 (4.38)
3rd
Universidade Federal de Minas Gerais
Brazil
562 (3.20)
4th
Tehran University of Medical Sciences
Iran
503 (2.86)
5th
Universidade Federal do Rio de Janeiro
Brazil
485 (2.76)
6th
Indian Institute of Chemical Biology
India
385 (2.19)
7th
Banaras Hindu University
India
371 (2.11)
8th
London School of Hygiene & Tropical Medicine
UK
345 (1.96)
9th
Prins Leopold Instituut voor Tropische Geneeskunde
Belgium
328 (1.87)
10th
Universidade Federal da Bahia
Brazil
323 (1.84)
SCR Standard competition ranking
Table 9
Top 10 institutions most productive of research publications on leishmaniasis from or collaborating with Arab world affiliations during 1998–2017
SCR a
Institute
Country
Number of documents (%)
1st
Institut Pasteur de Tunis
Tunisia
178 (17.93)
2nd
Khartoum University
Sudan
147 (14.80)
3rd
Institute of Endemic Diseases Sudan
Sudan
82 (8.26)
4th
Prins Leopold Instituut voor Tropische Geneeskunde
Belgium
40 (4.03)
5th
Charité – Universitätsmedizin Berlin
Germany
38 (3.83)
6th
University of Tunis El Manar
Tunisia
35 (3.52)
7th
Al-Quds University
Palestine
31 (3.12)
8th
Institut Pasteur - Alger
Algeria
30 (3.02)
8th
Universite de Montpellier
France
30 (3.02)
10th
Universite de Tunis El Manar, Hopital la Rabta
Tunisia
29 (2.92)
SCR Standard competition ranking
a Equal institutes have the same ranking number, and then a gap is left in the ranking numbers

Discussion

This study has made a comprehensive research on scientific research output of the Arab world relative to that worldwide in the field of leishmaniasis. The research findings have indicated that leishmaniasis has attracted more and more attention from Arab and worldwide scholars over the past decade. However, despite a significant growth of leishmaniasis publications in Arab world and at global level, the distributions are highly unbalanced at some regional levels. As a result of the current bibliometric analysis, researchers can get basic information on leishmaniasis research such as hot research topics in a historic perspective.
However, from the Arab world only the top five countries -Tunisia, Sudan, Saudi Arabia, Morocco and Egypt - ranked well at global level as regards the number of publications related to leishmaniasis research: 17th, 24th, 32nd, 34th, and 40th, respectively. The current study shows that Arab countries are lagging behind most developed and developing countries in the number of publications related to leishmaniasis in contrast with high prevalence rate leishmaniasis in Arab countries. The WHO Eastern Mediterranean Region reported a very high proportion (82%) of countries endemic for cutaneous and visceral leishmaniasis [4]. The status of the health-research system in the Arab world has been described previously in numerous areas of health such as dengue research [21], pharmaceutical wastewater research [57], integrative and complementary medicine research [58], toxicology research [59], tobacco smoking research [60], breast cancer research [61], and infectious disease research [62]. Health-research systems in the Arab world are perceived as being non-productive system due to low priority in national research funding levels and development planning [6365]. Despite the health services have improved in some Arab countries especially those with oil-based economies, the performance and development of their health-research system are lower than expected [66]. Generally, the amount of research related to medical field conducted in Arab world has grown considerably during the last decades and is still relatively small when compared with other world regions [61, 6769].
Compared the current findings with the findings from developed countries, the Arab world produced less leishmaniasis research. This may be related to a relatively indigent economy in most Arab countries as reported in the online database of the World Bank [70]. In addition to a high poverty-growth elasticity for most Arab countries [71] according to population size and gross domestic product (GDP) per capita [70], which may lead to inadequate funding to support leishmaniasis research. For that reason, governments in the Arab world should give more attention to leishmaniasis research by offering more manpower and materials to support it. Also, the developed world should be persuaded to grant more collaborative plans with Arab world, and to attract more funding for leishmaniasis research and disease control.
Brazil is by far the most prolific country and is responsible for the greatest of number of publications in the field of leishmaniasis. A possible explanation for this finding may be due to high prevalence of leishmaniasis in this country which was exposed to many outbreaks [4, 7275]. Additionally, other developing countries, such as India, and Iran, accounted in the most prolific countries in the field of the leishmaniasis research activity at global level, which may have been connected to a high prevalence of leishmaniasis in these countries [7678].
In this study, Tunisia and Sudan had the highest research productivity in the field leishmaniasis. Previous bibliometric studies have assessed different issues in biomedical field in the Arab world [21, 59, 61, 66, 7981]. Most of these studies found that Egypt and Saudi Arabia had the most research output among the Arab countries. No similar study has been found in a detailed literature search to address such those results but other related bibliometric studies have tried to make explanations for such findings [2022, 35]. A possible explanation for these findings may be referring to leishmaniasis prevalence rates which are higher in Tunisia and Sudan. According to WHO report, zoonotic cutaneous leishmaniasis in Tunisia is endemic and considered a major public health problem and the annual incidence is approximately 30 per 100,000 people [82]. In Sudan, visceral leishmaniasis has been among the most important health problems [83]. Nearly 90% of global cases of visceral leishmaniasis occurred in the following countries: Brazil, Bangladesh, Ethiopia, India, and Sudan [4, 6]. Additionally, Afghanistan, Algeria, Brazil, Colombia, the Islamic Republic of Iran, Iraq, Morocco, Peru, Sudan, the Syrian Arab Republic, Tunisia and Yemen represent 90% of cutaneous leishmaniasis cases that are reported worldwide [4].
Leishmaniasis treatment, intracellular mechanism of infection, and lifecycle of leishmania are the major current hot topics for the research in this subject at global level and the Arab world. Furthermore, the major current hot topics in the current study are presented by the research highlighted in the most highly-cited publications [6, 10, 3956], which gives an important and valuable insight into which publications and topics are motivating the research growth in this field over the time.
Similar to other studies [19, 33, 3537], some limitations of this bibliometric study should be addressed. Although Scopus is one of the most largest global database [84], it might contain most publications in the field of leishmaniasis research. The main limitation relays to the citation and publications count applied for journals indexed by the Scopus. The citation and publication counts in these journals do not include citations and publications published in non-Scopus-indexed journals.

Conclusions

The current study presents a novel review of the current Arab leishmaniasis-related research, and how these results are related to worldwide output. In summary, this study evaluated almost the last two decades of leishmaniasis literature output at the global level as well as the Arab world level. The findings of the current study indicated that Brazil was responsible for the greatest output in term of total number of publications in the field of leishmaniasis as indexed by Scopus during the period studied followed by the Unites States, India, the United Kingdom, and Spain. Additionally, Tunisia was responsible for the greatest output from Arab world followed by Sudan, Saudi Arabia, Morocco, and Egypt. In comparison to the global research output, the Arab world produced less leishmaniasis research. It can be concluded that research in the topics related to “leishmaniasis treatment”, “intracellular mechanism of infection”, and “lifecycle of leishmania” will undoubtedly continue to be the hotspots of leishmaniasis research at global level and the Arab world. In conclusion, the data presented in the current study by this innovative approach presents a clear picture on the research growth accomplished in the field of leishmania research, and may serve relevant researchers to direct the global leishmaniasis research as to Arab countries in which Leishmaniasis is endemic.

Acknowledgments

Not applicable.

Funding

No funding was received for this work.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request, and also can be retrieved from the Scopus database.
Since the current study did not meet criteria for Human Subjects Research, no formal consent and ethics approval were necessary in present such studies.
Not applicable.

Competing interests

The author declares that she has no competing interest.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6:147–54.CrossRef Ready PD. Epidemiology of visceral leishmaniasis. Clin Epidemiol. 2014;6:147–54.CrossRef
2.
Zurück zum Zitat Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951–70.CrossRef Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951–70.CrossRef
3.
Zurück zum Zitat Oliveira F, Jochim RC, Valenzuela JG, Kamhawi S. Sand flies, Leishmania, and transcriptome-borne solutions. Parasitol Int. 2009;58(1):1–5.CrossRef Oliveira F, Jochim RC, Valenzuela JG, Kamhawi S. Sand flies, Leishmania, and transcriptome-borne solutions. Parasitol Int. 2009;58(1):1–5.CrossRef
4.
Zurück zum Zitat World Health Organization. Global leishmaniasis update, 2006-2015: a turning point in leishmaniasis surveillance. Wkly Epidemiol Rec. 2017;92(38):557–65. World Health Organization. Global leishmaniasis update, 2006-2015: a turning point in leishmaniasis surveillance. Wkly Epidemiol Rec. 2017;92(38):557–65.
6.
Zurück zum Zitat Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366(9496):1561–77.CrossRef Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366(9496):1561–77.CrossRef
7.
Zurück zum Zitat Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, Moreno J. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev. 1997;10(2):298–319.CrossRef Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, Molina R, Moreno J. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev. 1997;10(2):298–319.CrossRef
8.
Zurück zum Zitat Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95(3):239–43.CrossRef Desjeux P. The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg. 2001;95(3):239–43.CrossRef
9.
Zurück zum Zitat Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2(8):494–501.CrossRef Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, Wasunna MK, Bryceson AD. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2(8):494–501.CrossRef
10.
Zurück zum Zitat Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581–96.CrossRef Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581–96.CrossRef
11.
Zurück zum Zitat Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med. 2016;9(10):925–32.CrossRef Oryan A, Akbari M. Worldwide risk factors in leishmaniasis. Asian Pac J Trop Med. 2016;9(10):925–32.CrossRef
12.
Zurück zum Zitat Di Muccio T, Scalone A, Bruno A, Marangi M, Grande R, Armignacco O, Gradoni L, Gramiccia M. Epidemiology of imported Leishmaniasis in Italy: implications for a European endemic country. PLoS One. 2015;10(6):e0129418.CrossRef Di Muccio T, Scalone A, Bruno A, Marangi M, Grande R, Armignacco O, Gradoni L, Gramiccia M. Epidemiology of imported Leishmaniasis in Italy: implications for a European endemic country. PLoS One. 2015;10(6):e0129418.CrossRef
13.
Zurück zum Zitat Jacobson RL. Leishmaniasis in an era of conflict in the Middle East. Vector Borne Zoonotic Dis. 2011;11(3):247–58.CrossRef Jacobson RL. Leishmaniasis in an era of conflict in the Middle East. Vector Borne Zoonotic Dis. 2011;11(3):247–58.CrossRef
14.
Zurück zum Zitat Karunaweera ND, Ferreira MU. Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region. Parasitology. 2018;145(4):425–29.CrossRef Karunaweera ND, Ferreira MU. Leishmaniasis: current challenges and prospects for elimination with special focus on the South Asian region. Parasitology. 2018;145(4):425–29.CrossRef
15.
Zurück zum Zitat Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the middle east: incidence and epidemiology. PLoS Negl Trop Dis. 2014;8(10):e3208.CrossRef Salam N, Al-Shaqha WM, Azzi A. Leishmaniasis in the middle east: incidence and epidemiology. PLoS Negl Trop Dis. 2014;8(10):e3208.CrossRef
16.
Zurück zum Zitat Bahrami F, Harandi AM, Rafati S. Biomarkers of Cutaneous Leishmaniasis. Front Cell Infect Microbiol. 2018;8:222.CrossRef Bahrami F, Harandi AM, Rafati S. Biomarkers of Cutaneous Leishmaniasis. Front Cell Infect Microbiol. 2018;8:222.CrossRef
17.
Zurück zum Zitat Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, Dedet JP, Campino L, Canavate C, Dujardin JC. Drug regimens for visceral leishmaniasis in Mediterranean countries. Tropical Med Int Health. 2008;13(10):1272–6.CrossRef Gradoni L, Soteriadou K, Louzir H, Dakkak A, Toz SO, Jaffe C, Dedet JP, Campino L, Canavate C, Dujardin JC. Drug regimens for visceral leishmaniasis in Mediterranean countries. Tropical Med Int Health. 2008;13(10):1272–6.CrossRef
18.
Zurück zum Zitat Hanney SR, Gonzalez-Block MA. Organising health research systems as a key to improving health: the world health report 2013 and how to make further progress. Health Res Policy Syst. 2013;11:47.CrossRef Hanney SR, Gonzalez-Block MA. Organising health research systems as a key to improving health: the world health report 2013 and how to make further progress. Health Res Policy Syst. 2013;11:47.CrossRef
19.
Zurück zum Zitat Sweileh WM, Al-Jabi SW, Sawalha AF, AbuTaha AS, Zyoud SH. Bibliometric analysis of worldwide publications on antimalarial drug resistance (2006-2015). Malar Res Treat. 2017;2017:6429410.PubMedPubMedCentral Sweileh WM, Al-Jabi SW, Sawalha AF, AbuTaha AS, Zyoud SH. Bibliometric analysis of worldwide publications on antimalarial drug resistance (2006-2015). Malar Res Treat. 2017;2017:6429410.PubMedPubMedCentral
20.
Zurück zum Zitat Zyoud SH. Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis. BMC Infect Dis. 2016;16:255.CrossRef Zyoud SH. Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis. BMC Infect Dis. 2016;16:255.CrossRef
21.
Zurück zum Zitat Zyoud SH. Dengue research: a bibliometric analysis of worldwide and Arab publications during 1872-2015. Virol J. 2016;13:78.CrossRef Zyoud SH. Dengue research: a bibliometric analysis of worldwide and Arab publications during 1872-2015. Virol J. 2016;13:78.CrossRef
22.
Zurück zum Zitat Zyoud SH. Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis. Health Res Policy Syst. 2017;15(1):14.CrossRef Zyoud SH. Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis. Health Res Policy Syst. 2017;15(1):14.CrossRef
23.
Zurück zum Zitat Hagel C, Weidemann F, Gauch S, Edwards S, Tinnemann P. Analysing published global Ebola virus disease research using social network analysis. PLoS Negl Trop Dis. 2017;11(10):e0005747.CrossRef Hagel C, Weidemann F, Gauch S, Edwards S, Tinnemann P. Analysing published global Ebola virus disease research using social network analysis. PLoS Negl Trop Dis. 2017;11(10):e0005747.CrossRef
24.
Zurück zum Zitat Okorie PN, Bockarie MJ, Molyneux DH, Kelly-Hope LA. Neglected tropical diseases: a systematic evaluation of research capacity in Nigeria. PLoS Negl Trop Dis. 2014;8(8):e3078.CrossRef Okorie PN, Bockarie MJ, Molyneux DH, Kelly-Hope LA. Neglected tropical diseases: a systematic evaluation of research capacity in Nigeria. PLoS Negl Trop Dis. 2014;8(8):e3078.CrossRef
25.
Zurück zum Zitat Perilla-Gonzalez Y, Gomez-Suta D, Delgado-Osorio N, Hurtado-Hurtado N, Baquero-Rodriguez JD, Lopez-Isaza AF, Lagos-Grisales GJ, Villegas S, Rodriguez-Morales AJ. Study of the scientific production on leishmaniasis in Latin America. Recent Pat Antiinfect Drug Discov. 2014;9(3):216–22.CrossRef Perilla-Gonzalez Y, Gomez-Suta D, Delgado-Osorio N, Hurtado-Hurtado N, Baquero-Rodriguez JD, Lopez-Isaza AF, Lagos-Grisales GJ, Villegas S, Rodriguez-Morales AJ. Study of the scientific production on leishmaniasis in Latin America. Recent Pat Antiinfect Drug Discov. 2014;9(3):216–22.CrossRef
26.
Zurück zum Zitat Vera-Polania F, Perilla-Gonzalez Y, Martinez-Pulgarin DF, Baquero-Rodriguez JD, Munoz-Urbano M, Lagos-Gallego M, Lagos-Grisales GJ, Villegas S, Rodriguez-Morales AJ. Bibliometric assessment of the Latin-American contributions in dengue. Recent Pat Antiinfect Drug Discov. 2014;9(3):195–201.CrossRef Vera-Polania F, Perilla-Gonzalez Y, Martinez-Pulgarin DF, Baquero-Rodriguez JD, Munoz-Urbano M, Lagos-Gallego M, Lagos-Grisales GJ, Villegas S, Rodriguez-Morales AJ. Bibliometric assessment of the Latin-American contributions in dengue. Recent Pat Antiinfect Drug Discov. 2014;9(3):195–201.CrossRef
27.
Zurück zum Zitat Gonzalez-Alcaide G, Huamani C, Park J, Ramos JM. Evolution of coauthorship networks: worldwide scientific production on leishmaniasis. Rev Soc Bras Med Trop. 2013;46(6):719–27.CrossRef Gonzalez-Alcaide G, Huamani C, Park J, Ramos JM. Evolution of coauthorship networks: worldwide scientific production on leishmaniasis. Rev Soc Bras Med Trop. 2013;46(6):719–27.CrossRef
28.
Zurück zum Zitat Ramos JM, Gonzalez-Alcaide G, Bolanos-Pizarro M. Bibliometric analysis of leishmaniasis research in Medline (1945-2010). Parasit Vectors. 2013;6:55.CrossRef Ramos JM, Gonzalez-Alcaide G, Bolanos-Pizarro M. Bibliometric analysis of leishmaniasis research in Medline (1945-2010). Parasit Vectors. 2013;6:55.CrossRef
29.
Zurück zum Zitat Soosaraei M, Khasseh AA, Fakhar M, Hezarjaribi HZ. A decade bibliometric analysis of global research on leishmaniasis in web of science database. Ann Med Surg (Lond). 2018;26:30–7.CrossRef Soosaraei M, Khasseh AA, Fakhar M, Hezarjaribi HZ. A decade bibliometric analysis of global research on leishmaniasis in web of science database. Ann Med Surg (Lond). 2018;26:30–7.CrossRef
30.
Zurück zum Zitat Huamani C, Romani F, Gonzalez-Alcaide G, Mejia MO, Ramos JM, Espinoza M, Cabezas C. South American collaboration in scientific publications on leishmaniasis: bibliometric analysis in SCOPUS (2000-2011). Rev Inst Med Trop Sao Paulo. 2014;56(5):381–90.CrossRef Huamani C, Romani F, Gonzalez-Alcaide G, Mejia MO, Ramos JM, Espinoza M, Cabezas C. South American collaboration in scientific publications on leishmaniasis: bibliometric analysis in SCOPUS (2000-2011). Rev Inst Med Trop Sao Paulo. 2014;56(5):381–90.CrossRef
31.
Zurück zum Zitat Zyoud SH. Estimates of global research productivity in using nicotine replacement therapy for tobacco cessation: a bibliometric study. Glob Health. 2018;14(1):14.CrossRef Zyoud SH. Estimates of global research productivity in using nicotine replacement therapy for tobacco cessation: a bibliometric study. Glob Health. 2018;14(1):14.CrossRef
32.
Zurück zum Zitat Cash-Gibson L, Rojas-Gualdron DF, Pericas JM, Benach J. Inequalities in global health inequalities research: a 50-year bibliometric analysis (1966-2015). PLoS One. 2018;13(1):e0191901.CrossRef Cash-Gibson L, Rojas-Gualdron DF, Pericas JM, Benach J. Inequalities in global health inequalities research: a 50-year bibliometric analysis (1966-2015). PLoS One. 2018;13(1):e0191901.CrossRef
33.
Zurück zum Zitat Al-Jabi SW. Global trends in aspirin resistance-related research from 1990 to 2015: a bibliometric analysis. Basic Clin Pharmacol Toxicol. 2017;121(6):512–9.CrossRef Al-Jabi SW. Global trends in aspirin resistance-related research from 1990 to 2015: a bibliometric analysis. Basic Clin Pharmacol Toxicol. 2017;121(6):512–9.CrossRef
34.
Zurück zum Zitat Singh N. Scientometric analysis of research on Zika virus. Virusdisease. 2016;27(3):303–6.CrossRef Singh N. Scientometric analysis of research on Zika virus. Virusdisease. 2016;27(3):303–6.CrossRef
35.
Zurück zum Zitat Al-Jabi SW. Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis. Glob Health. 2017;13(1):55.CrossRef Al-Jabi SW. Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis. Glob Health. 2017;13(1):55.CrossRef
36.
Zurück zum Zitat Sweileh WM, Al-Jabi SW, AbuTaha AS, Zyoud SH, Anayah FMA, Sawalha AF. Bibliometric analysis of worldwide scientific literature in mobile - health: 2006-2016. BMC Med Inform Decis Mak. 2017;17(1):72.CrossRef Sweileh WM, Al-Jabi SW, AbuTaha AS, Zyoud SH, Anayah FMA, Sawalha AF. Bibliometric analysis of worldwide scientific literature in mobile - health: 2006-2016. BMC Med Inform Decis Mak. 2017;17(1):72.CrossRef
37.
Zurück zum Zitat Sweileh WM, Al-Jabi SW, Zyoud SH, Sawalha AF. Bibliometric analysis of literature in pharmacy education: 2000-2016. Int J Pharm Pract. 2018. Sweileh WM, Al-Jabi SW, Zyoud SH, Sawalha AF. Bibliometric analysis of literature in pharmacy education: 2000-2016. Int J Pharm Pract. 2018.
38.
Zurück zum Zitat Nour SSOM. The incidence and transfer of knowledge within the Arab societies. J Knowl Econ. 2013;4(4):406–22.CrossRef Nour SSOM. The incidence and transfer of knowledge within the Arab societies. J Knowl Econ. 2013;4(4):406–22.CrossRef
39.
Zurück zum Zitat Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, de Boer M. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5).CrossRef Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, de Boer M. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5).CrossRef
40.
Zurück zum Zitat Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420(6915):502–7.CrossRef Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420(6915):502–7.CrossRef
41.
Zurück zum Zitat Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19(1):111–26.CrossRef Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev. 2006;19(1):111–26.CrossRef
42.
Zurück zum Zitat Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13(7):843–50.CrossRef Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, Flynn BJ, Hoff ST, Andersen P, Reed SG, Morris SL, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med. 2007;13(7):843–50.CrossRef
43.
Zurück zum Zitat Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305–18.CrossRef Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27(5):305–18.CrossRef
44.
45.
Zurück zum Zitat Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R, et al. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005;309(5733):436–42.CrossRef Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R, et al. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005;309(5733):436–42.CrossRef
46.
Zurück zum Zitat Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002;2(11):845–58.CrossRef Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002;2(11):845–58.CrossRef
47.
Zurück zum Zitat Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873–82.CrossRef Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, Alvar J, Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873–82.CrossRef
48.
Zurück zum Zitat Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med. 2002;346(12):891–5.CrossRef Alrajhi AA, Ibrahim EA, De Vol EB, Khairat M, Faris RM, Maguire JH. Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med. 2002;346(12):891–5.CrossRef
49.
Zurück zum Zitat Arnoult D, Akarid K, Grodet A, Petit PX, Estaquier J, Ameisen JC. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 2002;9(1):65–81.CrossRef Arnoult D, Akarid K, Grodet A, Petit PX, Estaquier J, Ameisen JC. On the evolution of programmed cell death: apoptosis of the unicellular eukaryote Leishmania major involves cysteine proteinase activation and mitochondrion permeabilization. Cell Death Differ. 2002;9(1):65–81.CrossRef
50.
Zurück zum Zitat Bacaer N, Guernaoui S. The epidemic threshold of vector-borne diseases with seasonality: the case of cutaneous leishmaniasis in Chichaoua, Morocco. J Math Biol. 2006;53(3):421–36.CrossRef Bacaer N, Guernaoui S. The epidemic threshold of vector-borne diseases with seasonality: the case of cutaneous leishmaniasis in Chichaoua, Morocco. J Math Biol. 2006;53(3):421–36.CrossRef
51.
Zurück zum Zitat El Tai NO, Osman OF, El Fari M, Presber W, Schönian G. Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing. Trans R Soc Trop Med Hyg. 2000;94(5):575–9.CrossRef El Tai NO, Osman OF, El Fari M, Presber W, Schönian G. Genetic heterogeneity of ribosomal internal transcribed spacer in clinical samples of Leishmania donovani spotted on filter paper as revealed by single-strand conformation polymorphisms and sequencing. Trans R Soc Trop Med Hyg. 2000;94(5):575–9.CrossRef
52.
Zurück zum Zitat Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet. 2000;356(9241):1565–9.CrossRef Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet. 2000;356(9241):1565–9.CrossRef
53.
Zurück zum Zitat Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, Kouriba B, Argiro L, el Kheir M, Bucheton B, Mary C, et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest. 2009;119(8):2379–87.PubMedPubMedCentral Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, Kouriba B, Argiro L, el Kheir M, Bucheton B, Mary C, et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest. 2009;119(8):2379–87.PubMedPubMedCentral
54.
Zurück zum Zitat Postigo JA. Leishmaniasis in the World Health Organization eastern Mediterranean region. Int J Antimicrob Agents. 2010;36 Suppl 1(SUPPL. 1:S62–5.CrossRef Postigo JA. Leishmaniasis in the World Health Organization eastern Mediterranean region. Int J Antimicrob Agents. 2010;36 Suppl 1(SUPPL. 1:S62–5.CrossRef
55.
Zurück zum Zitat Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3(2):87–98.CrossRef Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3(2):87–98.CrossRef
56.
Zurück zum Zitat Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, Groen J. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Tropical Med Int Health. 2001;6(2):108–13.CrossRef Zijlstra EE, Nur Y, Desjeux P, Khalil EA, El-Hassan AM, Groen J. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Tropical Med Int Health. 2001;6(2):108–13.CrossRef
57.
Zurück zum Zitat Zyoud SH, Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. Contribution of Arab countries to pharmaceutical wastewater literature: a bibliometric and comparative analysis of research output. Ann Occup Environ Med. 2016;28:28.CrossRef Zyoud SH, Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. Contribution of Arab countries to pharmaceutical wastewater literature: a bibliometric and comparative analysis of research output. Ann Occup Environ Med. 2016;28:28.CrossRef
58.
Zurück zum Zitat Zyoud SH, Al-Jabi SW, Sweileh WM. Scientific publications from Arab world in leading journals of integrative and complementary medicine: a bibliometric analysis. BMC Complement Altern Med. 2015;15:308.CrossRef Zyoud SH, Al-Jabi SW, Sweileh WM. Scientific publications from Arab world in leading journals of integrative and complementary medicine: a bibliometric analysis. BMC Complement Altern Med. 2015;15:308.CrossRef
59.
Zurück zum Zitat Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. A bibliometric analysis of toxicology research productivity in middle eastern Arab countries during a 10-year period (2003-2012). Health Res Policy Syst. 2014;12:4.CrossRef Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. A bibliometric analysis of toxicology research productivity in middle eastern Arab countries during a 10-year period (2003-2012). Health Res Policy Syst. 2014;12:4.CrossRef
60.
Zurück zum Zitat Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. A Scopus-based examination of tobacco use publications in middle eastern Arab countries during the period 2003-2012. Harm Reduct J. 2014;11:14.CrossRef Zyoud SH, Al-Jabi SW, Sweileh WM, Awang R. A Scopus-based examination of tobacco use publications in middle eastern Arab countries during the period 2003-2012. Harm Reduct J. 2014;11:14.CrossRef
61.
Zurück zum Zitat Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Contribution of Arab countries to breast cancer research: comparison with non-Arab middle eastern countries. BMC Womens Health. 2015;15:25.CrossRef Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Contribution of Arab countries to breast cancer research: comparison with non-Arab middle eastern countries. BMC Womens Health. 2015;15:25.CrossRef
62.
Zurück zum Zitat Sweileh WM, Al-Jabi SW, Abuzanat A, Sawalha AF, AbuTaha AS, Ghanim MA, Zyoud SH. Assessment of research productivity of Arab countries in the field of infectious diseases using web of science database. Infect Dis Poverty. 2015;4(1):2.CrossRef Sweileh WM, Al-Jabi SW, Abuzanat A, Sawalha AF, AbuTaha AS, Ghanim MA, Zyoud SH. Assessment of research productivity of Arab countries in the field of infectious diseases using web of science database. Infect Dis Poverty. 2015;4(1):2.CrossRef
63.
Zurück zum Zitat El-Azami-El-Idrissi M, Lakhdar-Idrissi M, Ouldim K, Bono W, Amarti-Riffi A, Hida M, Nejjari C. Improving medical research in the Arab world. Lancet. 2013;382(9910):2066–7.CrossRef El-Azami-El-Idrissi M, Lakhdar-Idrissi M, Ouldim K, Bono W, Amarti-Riffi A, Hida M, Nejjari C. Improving medical research in the Arab world. Lancet. 2013;382(9910):2066–7.CrossRef
64.
Zurück zum Zitat Sibai AM, Singh NV, Jabbour S, Saleh S, Abdulrahim S, Naja F, Yazbek S. Does published research on non-communicable disease (NCD) in Arab countries reflect NCD disease burden? PLoS One. 2017;12(6):e0178401.CrossRef Sibai AM, Singh NV, Jabbour S, Saleh S, Abdulrahim S, Naja F, Yazbek S. Does published research on non-communicable disease (NCD) in Arab countries reflect NCD disease burden? PLoS One. 2017;12(6):e0178401.CrossRef
65.
Zurück zum Zitat Nakkash R, Afifi R, Maziak W. Research and activism for tobacco control in the Arab world. Lancet. 2014;383(9915):392–3.CrossRef Nakkash R, Afifi R, Maziak W. Research and activism for tobacco control in the Arab world. Lancet. 2014;383(9915):392–3.CrossRef
66.
Zurück zum Zitat Benamer HT, Bakoush O. Arab nations lagging behind other middle eastern countries in biomedical research: a comparative study. BMC Med Res Methodol. 2009;9:26.CrossRef Benamer HT, Bakoush O. Arab nations lagging behind other middle eastern countries in biomedical research: a comparative study. BMC Med Res Methodol. 2009;9:26.CrossRef
67.
Zurück zum Zitat Saquib N, Zaghloul MS, Mazrou A, Saquib J. Cardiovascular disease research in Saudi Arabia: a bibliometric analysis. Scientometrics. 2017;112(1):111–40.CrossRef Saquib N, Zaghloul MS, Mazrou A, Saquib J. Cardiovascular disease research in Saudi Arabia: a bibliometric analysis. Scientometrics. 2017;112(1):111–40.CrossRef
68.
Zurück zum Zitat Al-Kindi S, Al-Juhaishi T, Haddad F, Taheri S, Abi Khalil C. Cardiovascular disease research activity in the Middle East: a bibliometric analysis. Ther Adv Cardiovasc Dis. 2015;9(3):70–6.CrossRef Al-Kindi S, Al-Juhaishi T, Haddad F, Taheri S, Abi Khalil C. Cardiovascular disease research activity in the Middle East: a bibliometric analysis. Ther Adv Cardiovasc Dis. 2015;9(3):70–6.CrossRef
69.
Zurück zum Zitat Jones AC, Geneau R. Assessing research activity on priority interventions for non-communicable disease prevention in low- and middle-income countries: a bibliometric analysis. Glob Health Action. 2012;5:1–13.CrossRef Jones AC, Geneau R. Assessing research activity on priority interventions for non-communicable disease prevention in low- and middle-income countries: a bibliometric analysis. Glob Health Action. 2012;5:1–13.CrossRef
72.
Zurück zum Zitat Jeronimo SM, Duggal P, Braz RF, Cheng C, Monteiro GR, Nascimento ET, Martins DR, Karplus TM, Ximenes MF, Oliveira CC, et al. An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in Northeast Brazil. Scand J Infect Dis. 2004;36(6–7):443–9.CrossRef Jeronimo SM, Duggal P, Braz RF, Cheng C, Monteiro GR, Nascimento ET, Martins DR, Karplus TM, Ximenes MF, Oliveira CC, et al. An emerging peri-urban pattern of infection with Leishmania chagasi, the protozoan causing visceral leishmaniasis in Northeast Brazil. Scand J Infect Dis. 2004;36(6–7):443–9.CrossRef
73.
Zurück zum Zitat Jeronimo SM, Oliveira RM, Mackay S, Costa RM, Sweet J, Nascimento ET, Luz KG, Fernandes MZ, Jernigan J, Pearson RD. An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg. 1994;88(4):386–8.CrossRef Jeronimo SM, Oliveira RM, Mackay S, Costa RM, Sweet J, Nascimento ET, Luz KG, Fernandes MZ, Jernigan J, Pearson RD. An urban outbreak of visceral leishmaniasis in Natal, Brazil. Trans R Soc Trop Med Hyg. 1994;88(4):386–8.CrossRef
74.
Zurück zum Zitat Silva ES, Gontijo CM, Pacheco RS, Fiuza VO, Brazil RP. Visceral leishmaniasis in the metropolitan region of Belo Horizonte, state of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 2001;96(3):285–91.CrossRef Silva ES, Gontijo CM, Pacheco RS, Fiuza VO, Brazil RP. Visceral leishmaniasis in the metropolitan region of Belo Horizonte, state of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz. 2001;96(3):285–91.CrossRef
75.
Zurück zum Zitat Werneck GL, Rodrigues L, Santos MV, Araujo IB, Moura LS, Lima SS, Gomes RB, Maguire JH, Costa CH. The burden of Leishmania chagasi infection during an urban outbreak of visceral leishmaniasis in Brazil. Acta Trop. 2002;83(1):13–8.CrossRef Werneck GL, Rodrigues L, Santos MV, Araujo IB, Moura LS, Lima SS, Gomes RB, Maguire JH, Costa CH. The burden of Leishmania chagasi infection during an urban outbreak of visceral leishmaniasis in Brazil. Acta Trop. 2002;83(1):13–8.CrossRef
76.
Zurück zum Zitat Muniaraj M. The lost hope of elimination of kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? Trop Parasitol. 2014;4(1):10–9.CrossRef Muniaraj M. The lost hope of elimination of kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities? Trop Parasitol. 2014;4(1):10–9.CrossRef
77.
Zurück zum Zitat Fakoorziba MR, Baseri A, Eghbal F, Rezaee S, Azizi K, Moemenbellah-Fard MD. Post-earthquake outbreak of cutaneous leishmaniasis in a rural region of southern Iran. Ann Trop Med Parasitol. 2011;105(3):217–24.CrossRef Fakoorziba MR, Baseri A, Eghbal F, Rezaee S, Azizi K, Moemenbellah-Fard MD. Post-earthquake outbreak of cutaneous leishmaniasis in a rural region of southern Iran. Ann Trop Med Parasitol. 2011;105(3):217–24.CrossRef
78.
Zurück zum Zitat Nateghi Rostami M, Saghafipour A, Vesali E. A newly emerged cutaneous leishmaniasis focus in Central Iran. Int J Infect Dis. 2013;17(12):e1198–206.CrossRef Nateghi Rostami M, Saghafipour A, Vesali E. A newly emerged cutaneous leishmaniasis focus in Central Iran. Int J Infect Dis. 2013;17(12):e1198–206.CrossRef
79.
Zurück zum Zitat Bayoumy K, MacDonald R, Dargham SR, Arayssi T. Bibliometric analysis of rheumatology research in the Arab countries. BMC Res Notes. 2016;9:393.CrossRef Bayoumy K, MacDonald R, Dargham SR, Arayssi T. Bibliometric analysis of rheumatology research in the Arab countries. BMC Res Notes. 2016;9:393.CrossRef
80.
Zurück zum Zitat Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Quantity and quality of obesity-related research in Arab countries: assessment and comparative analysis. Health Res Policy Syst. 2014;12:33.CrossRef Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Quantity and quality of obesity-related research in Arab countries: assessment and comparative analysis. Health Res Policy Syst. 2014;12:33.CrossRef
81.
Zurück zum Zitat Tadmouri GO, Bissar-Tadmouri N. Biomedical publications in an unstable region: the Arab world, 1988-2002. Lancet. 2003;362(9397):1766.CrossRef Tadmouri GO, Bissar-Tadmouri N. Biomedical publications in an unstable region: the Arab world, 1988-2002. Lancet. 2003;362(9397):1766.CrossRef
83.
Zurück zum Zitat Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2001;95(Suppl 1):S27–58.CrossRef Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2001;95(Suppl 1):S27–58.CrossRef
84.
Zurück zum Zitat Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–42.CrossRef Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–42.CrossRef
Metadaten
Titel
Arab world’s growing contribution to global leishmaniasis research (1998–2017): a bibliometric study
verfasst von
Samah W. Al-Jabi
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
BMC Public Health / Ausgabe 1/2019
Elektronische ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-6969-9

Weitere Artikel der Ausgabe 1/2019

BMC Public Health 1/2019 Zur Ausgabe